Kawasaki Syndrome
- 6 June 1991
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (23) , 1664-1666
- https://doi.org/10.1056/nejm199106063242311
Abstract
Kawasaki syndrome, first identified by Tomisaku Kawasaki, is a multisystem disease of young children that is also known as the mucocutaneous lymph node syndrome.1 The most serious complication is vasculitis of the coronary arteries. Kawasaki syndrome occurs worldwide and is a reportable disease in the United States, where the annual incidence is 4.5 to 8.5 cases per 100,000 children less than five years of age. When outbreaks occur, the incidence may rise to more than 150 per 100,000 children in a particular community. No evidence for a point source or for person-to-person transmission has ever been documented, however.The cause . . .Keywords
This publication has 9 references indexed in Scilit:
- A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki SyndromeNew England Journal of Medicine, 1991
- Treatment of Kawasaki syndrome: A comparison of two dosage regimens of intravenously administered immune globulinThe Journal of Pediatrics, 1990
- Management of Kawasaki syndromeThe Pediatric Infectious Disease Journal, 1989
- Intravenous γ-Globulin Use in Children With Kawasaki DiseasePublished by American Academy of Pediatrics (AAP) ,1988
- Frequency and size of coronary arterial aneurysm at necropsy in kawasaki diseaseThe American Journal of Cardiology, 1987
- Regression of coronary aneurysms in patients with Kawasaki syndrome.Circulation, 1987
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- Myocardial infarction in Kawasaki disease: Clinical analyses in 195 casesThe Journal of Pediatrics, 1986
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASEThe Lancet, 1984